Funding
The CREDENCE trial and this analysis were funded by Janssen Research & Development, LLC. Canagliflozin was developed by Janssen Research & Development, LLC, in collaboration with Mitsubishi Tanabe Pharma Corporation. Dr. Mohebi is supported by Barry Fellowship. Dr. Januzzi is supported by the Hutter Family Professorship.